Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.

Also called NCT01958320

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 202 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01958320
Other papers using this trial's data
  • Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320) Journal of perinatology : official journal of the California Perinatal Association, 2019-05 DOI, PubMed 30850756, PMC6561645 In the PMC Open Access subset under a licence that is not Creative Commons.
  • PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age The Journal of pediatrics, 2019-02 DOI, PubMed 30340932, PMC6502709 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Sweden, Türkiye, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01958320. Randomized; single masking; primary purpose treatment. Start 2013-12 (registry gives no type); primary completion 2017-06 (actual). Results posted on 2018-11-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Acronym
PDA:TOLERATE
Condition
Patent Ductus Arteriosus
Condition
Surgery
Condition
Necrotizing Enterocolitis
Condition
Intestinal Perforation
Intervention (Other)
pharmacologic treatment of the PDA
Intervention (Other)
no pharmacologic treatment of the PDA
Intervention (Drug)
NSAID
Lead sponsor
University of California, San Francisco (class: other)

Record details

Record id
cardio:ct-nct01958320
Content hash
fdea38f9c7270b04763702265205fe276a88798dd7b60f01f0c1501fbb888c3d